Prurigo Nodularis: Literature Review

K. Alrabiah
{"title":"Prurigo Nodularis: Literature Review","authors":"K. Alrabiah","doi":"10.23958/ijirms/vol08-i02/1615","DOIUrl":null,"url":null,"abstract":"Multiple, hard, flesh-to-pink papules, plaques, and nodules, often seen on the extensor surfaces of the limbs, are characteristic of prurigo nodularis, a persistent skin condition. The itchy lesions may strike people of any age. It often occurs in tandem with another condition that causes constant itching, such atopic dermatitis or another dermatosis. The clinical symptoms are the primary indicators. However, there may be numerous instances when lichen simplex chronic us and hypertrophic lichen planus are indistinguishable from a clinical standpoint. Therefore, it is crucial to confirm the diagnosis by dermoscopy and histology. Many other therapy strategies are being used, including those using powerful antipruritics, immunomodulators, and neuromodulators. After a diagnosis has been made, treatment might take a long time, thus patient education and counseling are crucial to ensuring they stick with the plan. A subset of chronic prurigo, prurigo nodularis (PN) manifests as hyperkeratotic, very itchy papules and nodules that are often seen in a symmetrical pattern. PN develops with persistent pruritus in the setting of a wide variety of dermatological, systemic, neurological, or mental disorders. Although the specific pathophysiology of PN is not well understood, chronic scratching may be a primary cause. Topical steroids, capsaicin, calcineurin inhibitors, ultraviolet (UV) treatment, systemic injection of gabapentinoids, -opioid receptor antagonists, antidepressants, and immunosuppressants are the current gold standard in treating PN. Clinical trials are being conducted on cutting-edge therapeutic modalities such blockers of neurokinin-1, opioid, and interleukin-31 receptors.","PeriodicalId":14008,"journal":{"name":"International Journal of Innovative Research in Medical Science","volume":"555 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Innovative Research in Medical Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23958/ijirms/vol08-i02/1615","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Multiple, hard, flesh-to-pink papules, plaques, and nodules, often seen on the extensor surfaces of the limbs, are characteristic of prurigo nodularis, a persistent skin condition. The itchy lesions may strike people of any age. It often occurs in tandem with another condition that causes constant itching, such atopic dermatitis or another dermatosis. The clinical symptoms are the primary indicators. However, there may be numerous instances when lichen simplex chronic us and hypertrophic lichen planus are indistinguishable from a clinical standpoint. Therefore, it is crucial to confirm the diagnosis by dermoscopy and histology. Many other therapy strategies are being used, including those using powerful antipruritics, immunomodulators, and neuromodulators. After a diagnosis has been made, treatment might take a long time, thus patient education and counseling are crucial to ensuring they stick with the plan. A subset of chronic prurigo, prurigo nodularis (PN) manifests as hyperkeratotic, very itchy papules and nodules that are often seen in a symmetrical pattern. PN develops with persistent pruritus in the setting of a wide variety of dermatological, systemic, neurological, or mental disorders. Although the specific pathophysiology of PN is not well understood, chronic scratching may be a primary cause. Topical steroids, capsaicin, calcineurin inhibitors, ultraviolet (UV) treatment, systemic injection of gabapentinoids, -opioid receptor antagonists, antidepressants, and immunosuppressants are the current gold standard in treating PN. Clinical trials are being conducted on cutting-edge therapeutic modalities such blockers of neurokinin-1, opioid, and interleukin-31 receptors.
结节性痒疹:文献综述
多发、坚硬、肉质至粉红色的丘疹、斑块和结节,常见于四肢伸肌表面,是结节性痒疹的特征,是一种持续性皮肤病。任何年龄的人都可能出现发痒的病变。它通常与另一种引起持续瘙痒的疾病同时发生,如特应性皮炎或其他皮肤病。临床症状是主要指标。然而,从临床的角度来看,可能有许多情况下单纯苔藓和肥厚性扁平苔藓难以区分。因此,通过皮肤镜检查和组织学检查来确诊是至关重要的。许多其他治疗策略正在使用,包括使用强效止痒药、免疫调节剂和神经调节剂。确诊后,治疗可能需要很长时间,因此对患者进行教育和咨询对于确保他们坚持治疗计划至关重要。结节性痒疹(PN)是慢性痒疹的一个亚型,表现为角化过度,非常痒的丘疹和结节,通常以对称模式出现。在各种皮肤、全身、神经或精神障碍的情况下,PN与持续性瘙痒一起发展。虽然PN的具体病理生理尚不清楚,但慢性抓挠可能是主要原因。局部类固醇、辣椒素、钙调磷酸酶抑制剂、紫外线(UV)治疗、全身注射加巴喷丁类药物、-阿片受体拮抗剂、抗抑郁药和免疫抑制剂是目前治疗PN的金标准。正在进行尖端治疗方式的临床试验,如神经激肽-1、阿片样物质和白细胞介素-31受体阻滞剂。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信